Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
06/2009
06/25/2009WO2009060122A3 Use of oligonucleotides with modified bases as antiviral agents
06/25/2009WO2009058911A3 Preparation and isolation of 5' capped mrna
06/25/2009WO2009054873A9 Anti-rantes antibodies and methods of use thereof
06/25/2009US20090165167 Means and Methods to Enhance the Production of Vinblastine and Vincristine in Catharanthus Roseus
06/25/2009US20090165166 Method to enhance yield and purity of hybrid crops
06/25/2009US20090165156 Method for increasing the saltwater tolerance of a fish
06/25/2009US20090163702 siRNA targeting Myeloid cell leukemia sequence 1
06/25/2009US20090163701 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA
06/25/2009US20090163432 Therapeutic Agent for Corneal Diseases
06/25/2009US20090163430 Functions and targets of let-7 micro rnas
06/25/2009US20090163429 Rna aptamers and methods for identifying the same
06/25/2009US20090163407 Compositions and methods for altering wnt autocrine signaling
06/25/2009US20090163405 Angiogenic peptides and uses thereof
06/25/2009US20090163382 Primer set for amplifying target sequence(s) of antibiotic-resistant bacterial species, probe or probe set specifically hybridizing with target sequence(s) of antibiotic-resistant bacterial species, method of detecting antibiotic-resistant bacterial species using the probe or probe set, and kit for detecting antibiotic-resistant bacterial species
06/25/2009US20090163372 Nucleolipids and use thereof, and devices for nucleic acid analysis
06/25/2009US20090163366 Two-primer sequencing for high-throughput expression analysis
06/25/2009US20090162932 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same
06/25/2009US20090162924 Compositions and methods for obtaining nucleic acids from sputum
06/25/2009US20090162916 Cellobiohydrolase i enzymes
06/25/2009US20090162909 Ketoreductase Polypeptides for the Production of Azetidinone
06/25/2009US20090162897 Promoter Sequences
06/25/2009US20090162894 A gene encoding a protein having an improved nitrile hydratase activity, whereby heat resistance has been improved or substrate specificity has been changed; for efficient production of acrylamide
06/25/2009US20090162868 Gene Markers and Utilization of the Same
06/25/2009US20090162866 Compositions and methods for obtaining nucleic acids from sputum
06/25/2009US20090162865 northern blotting, electrophoresis, PCR
06/25/2009US20090162852 Baalc expression as a diagnostic marker for acute leukemia
06/25/2009US20090162851 Target-specific hybrid capture (TSHC) for enhanced detection of homologous nucleotide sequences; classifying microorganisms; diagnosing infection, genetic abnormality and cell proliferative disorders; rapid, sensitive, highly specific and capable of discriminating highly homologous nucleic acids
06/25/2009US20090162850 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer
06/25/2009US20090162844 Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
06/25/2009US20090162838 Fluorescence resonance energy transfer enzyme substrates
06/25/2009US20090162836 Prognostic and Diagnostic Markers for Cell Proliferative Disorders of The Breast Tissues
06/25/2009US20090162831 human parvovirus
06/25/2009US20090162401 Streptococcus Iniae Phosphoglucomutase is a Virulence Factor and Target for Vaccine Development
06/25/2009US20090162398 Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
06/25/2009US20090162392 Mutant forms of streptolysin o
06/25/2009US20090162383 Method for designing vaccines against constantly mutating pathogens
06/25/2009US20090162382 Optimized ca9 antibodies and methods of using the same
06/25/2009US20090162380 Multispecific binding molecules comprising connecting peptides
06/25/2009US20090162375 Resistin antagonists and their use
06/25/2009US20090162366 Human monoclonal antibodies to influenza m2 protein and methods of making and using same
06/25/2009US20090162365 Novel siRNAS and methods of use thereof
06/25/2009US20090162364 Apo-2 ligand
06/25/2009US20090162363 Pedf-r receptor and uses
06/25/2009US20090162361 Method for diagnosing pancreatic cancer
06/25/2009US20090162343 Recombinant elastase proteins and methods of manufacturing and use thereof
06/25/2009US20090162321 Methods for packaging propagation-defective vesicular stomatitis virus vectors using a stable cell line that expresses g protein
06/25/2009US20090159842 Modular linkers for conjugation of organic substances to substantially inorganic substances and methods of manufacture and use thereof
06/25/2009DE102007062962A1 Neue Oberflächen-Protein-Mutante des Hepatitis B Virus HBV surface Antigen (HBsAg) New surface protein mutant of hepatitis B virus HBV surface antigen (HBsAg)
06/24/2009EP1620452B1 Treatment of nucleic acid
06/24/2009EP1451333B1 Ul16 binding protein 4
06/24/2009CN101466722A Methods for detecting mutations in JAK2 nucleic acid
06/24/2009CN101466721A Gene defect and mutant ALK kinase in human entity tumour
06/24/2009CN101466720A Processes for packaging oligonucleotides into virus-like particles of RNA bacteriophages
06/24/2009CN101463057A Chemical modification method of RNA EGS and use thereof in antiviral medicament preparation
06/24/2009CN100503830C Osmoregulation gene and protein and their preparation method and use
06/23/2009US7551271 Uncaging devices
06/23/2009US7550657 Inbred maize line PHANF
06/23/2009US7550583 Method of isolating, labeling and profiling small RNAs
06/23/2009US7550582 labeled Peptide Nucleic Acid (PNA) derivatives which carry one or more phosphoryl radicals at the N terminus of the PNA backbone for fluorescence in-situ hybridization (FISH) detection; can be purified using chromatography or electrophoresis; use as pharmaceuticals and diagnostic agents
06/23/2009US7550581 Guanosine derivatives and use thereof
06/23/2009US7550580 heat shock protein 27 inhibitors; RNA interference; nuclease resistance
06/23/2009US7550579 Pericarp-preferred regulatory element
06/23/2009US7550578 Rice promoters for regulation of plant expression
06/23/2009US7550577 Regulation of expression of high-affinity immunoglobulin E (IgE) receptor β-chain
06/23/2009US7550576 Nucleic acid sequences encoding two-component sensing and regulatory proteins, antimicrobial proteins and uses therefor
06/23/2009US7550575 Zea maize auxin response related genes for controlling plant growth and organ size and their use in improving crop plants
06/23/2009US7550573 Nucleotide sequences coding polypeptides for use in the treatment of thrombosis, arthritis and cell proliferation defects
06/23/2009US7550572 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response
06/23/2009US7550571 Lafora's disease gene
06/23/2009US7550566 G-CSF conjugates
06/23/2009US7550438 culture product protein obtained from culturing kidney epithelial cells of BSC-1 African green monkey kidney epithelial cell line; for perfusing ex vivo a donor human kidney, intended for transplantation into a new host; treating and diagnosing patients with kidney disease
06/23/2009US7550410 plurality of channels having a photoactivatable reagent flowing through interior and a light source to activate the reagent to biosynthesis; solution phase or solid phase synthesis for drug discovery; synthesis of biopolymer, oligonucleotides, peptides and carbohydrates
06/23/2009US7550300 Prediction of bare metal stent restenosis
06/23/2009US7550296 Identifying functional insertion sites within the genome of a replication competent target virus; result in an increase in the selectivity and efficiency of gene therapy
06/23/2009US7550293 Chimeric nicotinic receptor subunits
06/23/2009US7550286 Docosahexaenoic acid producing strains of Yarrowia lipolytica
06/23/2009US7550276 Utilizing predetermined sequences as quantitative tools in detection of target sequences; gene expression analysis and restriction fragment length polymorphisms; forensics
06/23/2009US7550274 Glucose dehydrogenase
06/23/2009US7550266 Methods and systems for dynamic gene expression profiling
06/23/2009US7550265 Process for removal of homopolymeric sequence portion from analyte(s) and library of analytes
06/23/2009US7550263 Fetoproteins; pharmacokinetics; biocompatability; rheumatoid arthritis; multiple sclerosis; cancer
06/23/2009US7550262 Identifying defects in protein tyrosine phosphatase gene and diagnosing and treating leukemic blood disorder
06/23/2009US7550261 Method of screening for drug hypersensitivity reaction
06/23/2009US7550154 encapsulate therapeutic compounds such as drugs, cellular materials or components, and antigens, and can have targeting ligands directly bound to the microparticle surface; tissue engineering matrices, wound dressings, bone repair or regeneration materials
06/23/2009CA2173822C Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion molecules in e. coli
06/23/2009CA2104767C A chemiluminescent method for the quantitation of human dna
06/21/2009CA2647856A1 Diagnostic test for cardiomyopathy
06/18/2009WO2009076226A1 Mutants of lysine decarboxylase, vaccines for periodontitis, and methods of use
06/18/2009WO2009074076A1 A complex molecule interfering the expression of target genes and its preparing methods
06/18/2009WO2009031835A4 Cell permeable nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same
06/18/2009WO2007059303A3 Compositions for coordinated vegf and pdgf expression, and methods of use
06/18/2009WO2007021841A3 Identification and engineering of antibodies with variant fc regions and methods of using same
06/18/2009WO2006113678A3 Methylation markers for diagnosis and treatment of cancers
06/18/2009WO2005084366A3 Transcription factor rna interference reagents and methods of use thereof
06/18/2009WO2004070002A3 Cell lines and host nucleic acid sequences related to infectious disease
06/18/2009WO2004055156A3 A vegf variant that lacks vegfr-1 binding activity and its use in promotion of re-endothelization and prevention of in-stent restenosis
06/18/2009WO2004024082A3 Highly specific modulators of gtpases for target validation
06/18/2009WO2004024077A3 Novel composition and methods for the treatment of psoriasis
06/18/2009WO2003074664A3 Cloning and characterization of slc26a7 and slc26a9 anion exchangers
06/18/2009WO2003072760A3 Method for cloning and expression of bsawi restriction endonuclease and bsawi methylase in e. coli